iRhythm Holdings Inc IRTC

Morningstar Rating
$116.13 −1.79 (1.51%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

IRTC is trading at a LOCK|^VDbX premium.
Price
$116.14
Fair Value
LOCK|>.VLpfR
Uncertainty
LOCK|$hf
1-Star Price
LOCK|^.Z>^>SG
5-Star Price
LOCK|%.fz%sF^r
Economic Moat
LOCK|St>f
Capital Allocation

News

Trading Information

Previous Close Price
$117.92
Day Range
$114.47118.08
52-Week Range
$100.85212.00
Bid/Ask
$115.51 / $116.79
Shares Outstanding
32.86M
Market Cap
$3.82B
Volume/Avg
478,642 / 555,763

Key Statistics

Price/Earnings (Normalized)
Price/Sales
5.12
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Total Yield

Company Profile

iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Growth
Total Number of Employees
2,400

Valuation

Metric
IRTC
Price/Earnings (Normalized)
Price/Book Value
25.49
Price/Sales
5.12
Price/Cash Flow
21.75
Price/Earnings
No chart available

Financial Strength

Metric
IRTC
Quick Ratio
4.79
Current Ratio
5.17
Interest Coverage
−2.69
Quick Ratio
IRTC

Profitability

Metric
IRTC
Return on Assets (Normalized)
−1.41%
Return on Equity (Normalized)
−11.05%
Return on Invested Capital (Normalized)
−2.38%
Return on Assets
IRTC

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|P>@&<BlLOCK|#YF%%$164B
Stryker Corp
SYK
LOCK|P?<vRM?gLOCK|yFZ$126B
Medtronic PLC
MDT
LOCK|XW^Yp<LOCK|Kz%V$107B
Boston Scientific Corp
BSX
LOCK|G!X#N%LOCK|N?C%$67B
Edwards Lifesciences Corp
EW
LOCK|>BPH?#yLOCK|%qm^$53B
GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|J?HGSdGLOCK|tjk$29B
DexCom Inc
DXCM
LOCK|<t#f$<Z>LOCK|<@ng$29B
Koninklijke Philips NV ADR
PHG
LOCK|j^xLOCK|$!$27B
Steris PLC
STE
LOCK|P>!Nj$LOCK|YNq?$21B
Zimmer Biomet Holdings Inc
ZBH
LOCK|Cx$@kP$LOCK|d^&$18B

Sponsor Center